Compare NUVL & NFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NUVL | NFG |
|---|---|---|
| Founded | 2017 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil/Gas Transmission |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 7.3B |
| IPO Year | 2021 | N/A |
| Metric | NUVL | NFG |
|---|---|---|
| Price | $107.07 | $81.36 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 15 | 5 |
| Target Price | ★ $135.00 | $91.20 |
| AVG Volume (30 Days) | 552.5K | ★ 765.2K |
| Earning Date | 02-26-2026 | 01-28-2026 |
| Dividend Yield | N/A | ★ 2.66% |
| EPS Growth | N/A | ★ 576.19 |
| EPS | N/A | ★ 5.68 |
| Revenue | N/A | ★ $2,277,541,000.00 |
| Revenue This Year | N/A | $15.96 |
| Revenue Next Year | N/A | $24.46 |
| P/E Ratio | ★ N/A | $14.18 |
| Revenue Growth | N/A | ★ 17.11 |
| 52 Week Low | $55.54 | $63.66 |
| 52 Week High | $112.88 | $94.13 |
| Indicator | NUVL | NFG |
|---|---|---|
| Relative Strength Index (RSI) | 54.67 | 52.56 |
| Support Level | $97.43 | $77.80 |
| Resistance Level | $108.46 | $82.53 |
| Average True Range (ATR) | 4.64 | 1.64 |
| MACD | 0.41 | 0.03 |
| Stochastic Oscillator | 81.51 | 70.61 |
Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.
National Fuel Gas Co is a diversified energy company engaged in the production, gathering, transportation, distribution, and marketing of natural gas. The operating segments of the company are the Exploration and Production segment, the Pipeline and Storage segment, the Gathering segment, and the Utility segment. The company generates a majority of its revenue from the Exploration and Production segment which is engaged in the exploration for, and the development and production of, natural gas in the Appalachian region of the United States. Geographically, the company operates in the United States.